Infleqtion (CCCX) director awarded 33,928 options at $12.59 strike
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
Infleqtion, Inc. reported that director David B. Singer was granted stock options covering 33,928 shares of common stock at an exercise price of $12.59 per share. The options vest in full on the earlier of May 23, 2027 or the issuer's next annual stockholder meeting after April 10, 2026, subject to his continuous service. These options expire on April 10, 2036. According to the disclosure, the economic benefit of this director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
SINGER DAVID B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 33,928 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 33,928 shares (Direct)
Footnotes (1)
- The options vest in full on the earlier of (i) May 23, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders following April 10, 2026, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2026 Equity Incentive Plan) with the Issuer through such date. Vesting shall be subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy. The economic benefit of the director compensation provided in respect of the Reporting Person's board service passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
Key Figures
Option grant size: 33,928 options
Exercise price: $12.59 per share
Post-grant derivative holdings: 33,928 options
+1 more
4 metrics
Option grant size
33,928 options
Stock options covering 33,928 shares granted to director
Exercise price
$12.59 per share
Fixed exercise price for the stock option grant
Post-grant derivative holdings
33,928 options
Total stock options held following this grant
Expiration date
April 10, 2036
Options expire on April 10, 2036 if unexercised
Key Terms
Stock Option (Right to Buy), Continuous Service, 2026 Equity Incentive Plan, Non-Employee Director Compensation Policy, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Continuous Service financial
"subject to the Reporting Person's Continuous Service with the Issuer"
2026 Equity Incentive Plan financial
"as defined in the Issuer's 2026 Equity Incentive Plan"
Non-Employee Director Compensation Policy financial
"subject to any acceleration provisions contained in the Issuer's Non-Employee Director Compensation Policy"
management fee offset financial
"passes to Maverick Ventures Investment Fund, L.P. through a management fee offset"
pecuniary interest financial
"disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest"
FAQ
What did Infleqtion (CCCX) disclose about David B. Singer's compensation?
Infleqtion disclosed a grant of stock options to director David B. Singer covering 33,928 shares of common stock at a $12.59 exercise price. The award reflects compensation for his board service and is documented in an amended insider ownership report.
When do David B. Singer’s Infleqtion (CCCX) options vest?
The options vest in full on the earlier of May 23, 2027 or the date of Infleqtion’s next annual stockholder meeting after April 10, 2026. Vesting is conditioned on his continuous service and subject to any acceleration under the company’s director compensation policy.
What is the exercise price and expiration date of the Infleqtion (CCCX) options?
The options have a $12.59 per share exercise price and expire on April 10, 2036. This means they can be exercised at that fixed price any time after vesting and before expiration, subject to the applicable plan and agreement terms.
Who ultimately benefits economically from this Infleqtion (CCCX) option grant?
The filing states that the economic benefit of the director compensation passes to Maverick Ventures Investment Fund, L.P. through a management fee offset. David B. Singer disclaims beneficial ownership of the securities except to the extent of his pecuniary interest in them.